A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
PHASE3CompletedINTERVENTIONAL
Enrollment
153
Participants
Timeline
Start Date
May 17, 2016
Primary Completion Date
March 15, 2017
Study Completion Date
June 7, 2017
Conditions
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis CCompensated Cirrhosis and Non-cirrhotics